Диссертация (1141143), страница 16
Текст из файла (страница 16)
27.– p. 2858–2865.75.Law E.H., Gordon W. Target-specific oral anticoagulants in patientsundergoing cardioversion // Am J Health Syst Pharm. – 2014. – Vol. 17(14). – p. 1171–1176.76.Lehmann G., Horcher J., Dennig K., Plewan A., Ulm K., Alt E. Atrialmechanical performance after internal and external cardioversion of atrial fibrillation:an echocardiographic study // Chest. – 2002. – Vol. 121. – p. 13–18.77.Lip G.Y. The role of aspirin for stroke prevention in atrial fibrillation //Nat Rev Cardiol. – 2011. – Vol. 8. – p. 602–606.78.Lip G.Y., Frison L., Halperin J.L., Lane D.A. Comparative validation of anovel risk score for predicting bleeding risk in anticoagulated patients with atrialfibrillation: the HAS-BLED (Hypertension, Abnormal renal/liver function, Stroke,Bleeding history or predisposition, Labile INR, Elderly, Drugs/alcohol concomitantly)score // J Am Coll Cardiol.
– 2011. – Vol. 57. – p. 173–180.79.Lip G.Y., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J. Refiningclinical risk stratification for predicting stroke and thromboembolism in atrialfibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrialfibrillation // Chest. – 2010. – Vol. 137. – p. 263–272.80.Logan W.F., Rowlands D.J., Howitt G., Holmes A.M. Left atrial activityfollowing cardioversion // Lancet. – 1965.
– Vol. 2. – p. 471–473.81.Manning W.J., Leeman D.E., Gotch P.J. et al. Pulsed Doppler evaluationof atrial mechanical function after electrical cardioversion of atrial fibrillation // J AmColl Cardiol. – 1989. – Vol. 13. – p. 617–623.82.Manning W.J., Silverman D.I., Katz S.E. et al. Impaired left atrialmechanical function after cardioversion: relation to the duration of atrial fibrillation //Journal of the American College of Cardiology.– 1994.– Vol. 23.– p.
1535–1540.10683.Manning W.J., Silverman D.I., Katz S.E. et al. Temporal dependence ofthe return of atrial mechanical function on the mode of cardioversion of atrialfibrillation to sinus rhythm // The American journal of cardiology.– 1995.– Vol. 75.– p.624–626.84.Manning W.J., Silverman D.I., Waksmonski C.A.
et al. Prevalence ofresidual left atrial thrombi among patients with acute thromboembolism and newlyrecognized atrial fibrillation // Arch Intern Med. – 1995. – Vol. 155. – p. 2193–2198.85.Manning W.J., Weintraub R.M., Waksmonski C.A., Haering J.M., RooneyP.S., Maslow A.D., Johnson R.G., Douglas P.S.
Accuracy of transesophagealechocardiography for identifying left atrial thrombi: a prospective, intraoperative study// Ann Intern Med. – 1995. – Vol. 123. – p. 817–822.86.Mant J., Hobbs F.D., Fletcher K., Roalfe A., Fitzmaurice D., Lip G.Y.,Murray E. Warfarin versus aspirin for stroke prevention in an elderly communitypopulation with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of theAged Study, BAFTA): a randomised controlled trial // Lancet. – 2007.
– Vol. 370. – p.493–503.87.Mazzone C., Pandullo C., Scardi S. et al. Left atrial and appendagemechanical function after pharmacological or electrical cardioversion in patients withchronic atrial fibrillation: a multicenter, randomized study // Ital Heart J. – 2000. – Vol.1. – p.
128–136.88.Michelena H.I., Ezekowitz M.D. Atrial fibrillation: are there genderdifferences? // J Gend Specif Med. – 2000. – Vol. 3. – p. 44–49.89.Moreyra E., Finkelhor R.S., Cebul R.D. Limitations of transesophagealechocardiography in the risk assessment of patients before nonanticoagulatedcardioversion from atrial fibrillation and flutter: an analysis of pooled trials // AmHeart J.
– 1995. – Vol. 129. – p. 71–75.90.Mugge A., Kuhn H., Nikutta P. et al. Assessment of left atrial appendagefunction by biplane transesophageal echocardiography in patients with nonrheumatic107atrial fibrillation: identification of a subgroup of patients at increased embolic risk // JAmColl Cardiol. – 1994. – Vol. 23. – p. 599–607.91.Nagarakanti R., Ezekowitz M., Oldgren J. et al. Dabigatran versuswarfarin in patients with atrial fibrillation: an analysis of patients undergoingcardioversion // Circulation.
– 2011. – Vol. 123. – p. 131–136.92.Neumann T., Erdogan A., Reiner C., Siemon G., Kurzidim K.,Berkowitsch A. et al. HF ambulatory electrocardioversion of atrial fibrillation bymeans of biphasic versus monophasic shock delivery. A prospective randomized study// Z Kardiol. – 2004. – Vol. 93. – p. 381–387.93.Nuotio I., Hartikainen J.E., Gronberg T., Biancari F., Airaksinen K.E.Time to cardioversion for acute atrial fibrillation and thromboembolic complications. //JAMA.– 2014.– Vol.
312.– p. 647–649.94.Ogilvie I.M., Welner S.A., Cowell W., Lip G.Y. Ischaemic stroke andbleeding rates in ’real-world’ atrial fibrillation patients // Thromb Haemost. – 2011. –Vol. 106. – p. 34–44.95.Olesen J.B., Lip G.Y., Hansen P.R., Lindhardsen J., Ahlehoff O.,Andersson C., Weeke P., Hansen M.L., Gislason G.H., Torp-Pedersen C. Bleeding riskin ‘real world’ patients with atrial fibrillation: comparison of two established bleedingprediction schemes in a nationwide cohort // J Thromb Haemost.
– 2011. – Vol. 9. – p.1460–1467.96.Olesen J.B., Lip G.Y., Lindhardsen J., Lane D.A., Ahlehoff O., HansenM.L., Raunsø J., Tolstrup J.S., Hansen P.R., Gislason G.H., Torp-Pedersen C. Risks ofthromboembolism and bleeding with thromboprophylaxis in patients with atrialfibrillation: a net clinical benefit analysis using a ‘real world’ nationwide cohort study// Thromb Haemost. – 2011. – Vol. 106. – p. 739–749.97.Omran H., Jung W., MacCarter D. et al.
Right atrial thrombi anddepressed right atrial appendage function after cardioversion of atrial fibrillation //Echocardiography. – 1999. – Vol. 16. – p. 245–251.10898.Omran H., Jung W., Rabahieh R. et al. Left Atrial chamber and appendagefunction after internal atrial defibrillation: a prospective and serial transesophagealechocardiographic study // Journal of the American College of Cardiology.– 1997.–Vol. 29.– p. 131–138.99.Oram S., Davies J.P. Further experience of electrical cardioversion ofatrial fibrillation to sinus rhythm: analysis of 100 patients // Lancet.
– 1964. – Vol. 1. –p. 1294–1298.100. Pallisgaard J.L., Lindhardt T.B., Hansen M.L., Schjerning A.M., OlesenJ.B., Staerk L., Torp-Pedersen C., Gislason G.H. Cardioversion and risk of adverseevents with dabigatran versus warfarin - a nationwide cohort study // PLoS One. –2015. – Vol. 10. – p. 1–11.101. Patel M.R., Mahaffey K.W., Garg J., Pan G., Singer D.E., Hacke W.,Breithardt G., Halperin J.L., Hankey G.J., Piccini J.P., Becker R.C., Nessel C.C.,Paolini J.F., Berkowitz S.D., Fox K.A.A., Califf R.M. and the ROCKET AF SteeringCommittee, for the ROCKET AF Investigator. Rivaroxaban versus Warfarin inNonvalvular Atrial Fibrillation // N Engl J Med.– 2011.– Vol.
365.– p. 883–891.102. Paventi S., Parafati M., Pellegrino C. Atrial stunning and pharmacologiccardioversion in idiopathic atrial fibrillation of recent onset // Minerva Cardioangiol.–1999.– Vol. 47.– p. 239–244.103. Pearson A.C., Labovitz A.J., Tatineni S., Gomez C.R. Superiority oftransesophageal echocardiography in detecting cardiac source of embolism in patientswith cerebral ischemia of uncertain etiology // J Am Coll Cardiol.– 1991.– Vol.
17.– p.66–72.104. Ricard P., Levy S., Boccara G., Lakhal E., Bardy G. Externalcardioversion of atrial fibrillation: comparison of biphasic vs. monophasic waveformshocks // Europace.– 2001.– Vol. 3.– p. 96–99.105. Rosendaal F.R., Cannegieter S.C., van der Meer F.J., Briet E. A method todetermine the optimal intensity of oral anticoagulant therapy // Thromb Haemost.–1993.– Vol. 69.– p. 236-239.109106. Roy D., Talajic M., Nattel S., Wyse D.G., Dorian P., Lee K.L.
et al. for theAtrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versusrate control for atrial fibrillation and heart failure // N Engl J Med.– 2008.– Vol. 358.–p. 2667–2677.107. Sanders P., Morton J.B., Morgan J.G. et al. Reversal of atrial mechanicalstunning after cardioversion of atrial arrhythmias: implications for the mechanisms oftachycardia-mediated atrial cardiomyopathy // Circulation.– 2002.– Vol. 106.– p.1806–1813.108. Shapiro E.P., Effron M.B., Lima S., Ouyang P., Siu C.O., Bush D.Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinusrhythm // Am J Cardiol.– 1988.– Vol. 62.– p. 1202–1207.109. Sparks P.B., Jayaprakash S., Vohra J.K.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
